Impairing the radioresistance of cancer cells by hydrogenated nanodiamonds

Romain Grall, Hugues A. Girard, Lina Saad, Tristan Petit, C. Gesset, Mathilde Combis-Schlumberger, Vincent Paget, Jozo Delić, Jean‐Charles Arnault, Sylvie Chevillard

Biomaterials · 2015 · 76 citations · 43 references

DOIFull text

Open access

Concepts

Abstract

Hydrogenated nanodiamonds (H-NDs) exhibit a negative electron affinity that confers a high reactivity with oxygen species and a positive charge in aqueous solutions. It allows electron emission from H-NDs following irradiation by photons and in consequence may enhance the effects of radiation on cancer cells. By using three human radioresistant cancer cell lines, we showed a potentialization of cytotoxicity after a co-exposure to H-NDs and irradiation; an event occurring through the induction of DNA damage and reactive oxygen species. This occurred together with a decrease in cell impedance, the activation of G1/S, an unlocking of G2 cell cycle check-points and early low cell death rate. At later stage of exposure, persistent increases in heterochromatinization, large γ-H2AX foci and β-galactosidase activity were detected providing evidence of cells' entrance into senescence. Similar potentialization was observed with neocarzinostatin (NCS), a radiomimetic drug. This original finding underlines a wide clinical potential of H-NDs to intensify radiation effects on radio-resistant cancer cells.

References

43